Dr. Cassandra J. Meakin Honored with Early Career Achievement Award

In a significant acknowledgment of her contributions to toxicological research, Dr. Cassandra J. Meakin, a toxicologist at Gradient, has been awarded the Early Career Achievement Award by the Medical Device and Combination Products Specialty Section of the Society of Toxicology (SOT). This prestigious recognition was presented to her during an evening reception at the SOT 65th Annual Meeting and ToxExpo on March 23, 2026, held in the sunny city of San Diego, California.

The Early Career Achievement Award honors the achievements of young scientists who have shown exceptional promise in their early careers. Dr. Meakin’s award comes as a result of her groundbreaking research on endocrine and reproductive chemical identification that is directly relevant to medical devices. Her notable work titled “Identification of Chemicals of Endocrine and Reproductive Concern in Medical Device Extractables and Leachables Datasets” aims at cataloging the presence and distribution of compounds that may lead to endocrine disruption or reproductive toxicity in materials used for medical devices. This research is crucial as it sheds light on potential risks that certain chemicals posed to human health within real-world scenarios.

As a board-certified toxicologist, Dr. Meakin possesses extensive expertise in conducting biological safety evaluations and undertaking toxicological risk assessments concerning both medical devices and pharmaceuticals. Her role requires a comprehensive evaluation of human health risks associated with chemical exposures and involves providing guidance for regulatory compliance to various US and international agencies. Her findings not only underline the importance of rigorous safety assessments for new medical technologies but also aim to influence future regulatory guidelines in the medical device sector.

Gradient, the leading environmental and risk sciences consulting firm where Dr. Meakin works, is recognized for its commitment to scientific excellence. The organization is dedicated to offering innovative risk sciences consulting services with the aim to devise effective strategies and solutions that are responsive to environmental and human health challenges.

The importance of Dr. Meakin's work cannot be understated, especially in a time where the safety and efficacy of medical devices are under increasing scrutiny. Her passion for toxicological research and dedication to improving public health safety continues to inspire both her colleagues and aspiring scientists in the field.

As we celebrate Dr. Meakin's exceptional achievement, we encourage our readers to stay informed about the ongoing advancements in toxicology and the efforts made by dedicated professionals like her in safeguarding human health. Congratulations, Dr. Cassandra J. Meakin, for this well-deserved honor that highlights your commitment to excellence in toxicological science!